ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Ruxolitinib attenuates diethylnitrosamine-induced liver injury in mice: involvement of TLR4/MYD88/NF-κB and IL-6/JAK/STAT pathways.

Doaa H Hegazy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.